Fanni Egidia, Castellini Giovanni, Corona Giovanni, Boddi Valentina, Ricca Valdo, Rastrelli Giulia, Fisher Alessandra Daphne, Cipriani Sarah, Maggi Mario
Andrology Unit, Sexual Medicine and Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Psychology, Drug Research and Child Health, Department of Neuroscience, University of Florence, Florence, Italy.
J Sex Med. 2016 Sep;13(9):1395-1407. doi: 10.1016/j.jsxm.2016.07.002.
An important feature of somatic symptom disorder is the subjective perception of the physical symptoms and its maladaptive interpretation. Considering that psychological distress is often expressed through somatic symptoms, it is possible that they underlie at least a part of the symptoms in subjects complaining of sexual dysfunction. Nevertheless, studies on the impact of somatoform disorders in sexual dysfunction are scanty.
To define the psychological, relational, and organic correlates of somatic symptoms in a large sample of patients complaining of sexual problems.
A consecutive series of 2833 men (mean age 50.2 ± 13.5 years) was retrospectively studied.
Somatic symptoms were assessed using the "somatized anxiety symptoms" subscale of the Middlesex Hospital Questionnaire (MHQ-S). Several clinical, biochemical, psychological, and relational parameters were studied. Patients were interviewed with the previously validated Structured Interview on Erectile Dysfunction (SIEDY), and ANDROTEST (a structured interview for the screening of hypogonadism in patients with sexual dysfunction).
Among the 2833 patients studied, subjects scoring higher on somatic symptoms were older, more obese, reporting unhealthy lifestyle (current smoking, alcohol consumption), and a lower education (all P < .05). Moreover, they reported a general impairment of their sexuality more often, including erectile problems (spontaneous or sexual-related), low sexual desire, decreased frequency of intercourse, and perceived reduction of ejaculate volume (all P < .005). Interestingly, we observed a significant association between MHQ-S scoring with a reduced testosterone level and hypogonadism symptoms (both P < .05). Finally, we found a significant association between somatic symptoms and both SIEDY Scales 1 (organic domain of ED) and 3 (intrapsychic domain of ED) (both P < .0001).
The present study demonstrates that the presence of somatic symptoms can represent an important contextual factor in the determination of or in the exacerbation of male sexual dysfunction. High levels of somatic symptoms in subjects with sexual dysfunction can be related to the sexual symptom itself. The consequences of this pattern have great clinical relevance in a sexual medicine setting, considering their severe impact on sexuality.
躯体症状障碍的一个重要特征是对躯体症状的主观感受及其适应不良的解释。鉴于心理困扰常通过躯体症状表现出来,在主诉性功能障碍的患者中,这些症状可能至少构成部分症状的基础。然而,关于躯体形式障碍对性功能障碍影响的研究较少。
在大量主诉性问题的患者样本中,确定躯体症状的心理、人际关系和器质性相关因素。
对连续的2833名男性(平均年龄50.2±13.5岁)进行回顾性研究。
使用米德尔塞克斯医院问卷(MHQ-S)的“躯体化焦虑症状”子量表评估躯体症状。研究了几个临床、生化、心理和人际关系参数。患者接受了先前验证过的勃起功能障碍结构化访谈(SIEDY)以及ANDROTEST(一种用于筛查性功能障碍患者性腺功能减退的结构化访谈)。
在研究的2833名患者中,躯体症状得分较高的受试者年龄较大、更肥胖,报告有不健康的生活方式(当前吸烟、饮酒)且教育程度较低(所有P<.05)。此外,他们更常报告性功能普遍受损,包括勃起问题(自发或与性相关)、性欲低下、性交频率降低以及射精量减少(所有P<.005)。有趣的是,我们观察到MHQ-S得分与睾酮水平降低和性腺功能减退症状之间存在显著关联(两者P<.05)。最后,我们发现躯体症状与SIEDY量表1(勃起功能障碍的器质性领域)和3(勃起功能障碍的心理内部领域)均存在显著关联(两者P<.0001)。
本研究表明,躯体症状的存在可能是男性性功能障碍发生或加重的一个重要背景因素。性功能障碍患者中高水平的躯体症状可能与性症状本身有关。考虑到这种模式对性功能的严重影响,其后果在性医学环境中具有重大的临床意义。